Daily Sepsis Research Analysis

In 2,015 critically ill children, the incidence of disseminated intravascular coagulation varied substantially according to the diagnostic system used. In children with sepsis, sepsis-induced coagulopathy criteria showed higher sensitivity and area under the curve for mortality discrimination than overt DIC criteria, supporting combined SIC and DIC screening.

Impact: This study directly addresses the lack of consensus regarding pediatric DIC diagnosis and provides subgroup-specific evidence for sepsis and hematologic malignancy. Its findings could improve early recognition and risk stratification in pediatric intensive care.

Clinical Implications: For critically ill children with suspected sepsis-associated coagulopathy, SIC criteria may support earlier detection, while combining SIC-ISTH with DIC-ISTH criteria may improve screening for overt DIC. Local validation and prospective implementation studies are needed before universal adoption.

Future Directions: Prospective multicenter studies should validate combined SIC-DIC algorithms, assess their effect on treatment timing and outcomes, and determine whether thresholds should be tailored to specific pediatric subgroups.

The synthetic sulfonamide intermediate FMM improved survival and reduced inflammatory injury in a Pseudomonas aeruginosa-induced sepsis model. Its effects were associated with enhanced bone marrow neutrophil maturation, reactive oxygen species generation, and neutrophil extracellular trap formation through an autophagy-related host-directed mechanism.

Impact: The study proposes a non-antibiotic, host-directed strategy that targets neutrophil development and function rather than directly targeting pathogens. This mechanism could be valuable in sepsis complicated by antimicrobial resistance, although clinical translation remains preliminary.

Clinical Implications: FMM provides a preclinical rationale for developing host-directed sepsis therapies that enhance innate immune competence. It should not yet be used clinically; pharmacokinetic, toxicity, infection-spectrum, and mammalian translational studies are required.

Future Directions: Future work should define the molecular target and GPCR pathway, confirm efficacy in polymicrobial and clinically relevant sepsis models, establish pharmacology and toxicity, and evaluate whether FMM can be combined safely with antibiotics and organ-support therapies.

This multicenter retrospective study analyzed 709 Moraxella blood-culture isolates from 56 European hospitals. M. osloensis predominated overall, M. catarrhalis was more common in children, M. atlantae was more common in adults, and most isolates remained susceptible to several commonly used agents, although cefotaxime resistance in M. osloensis was substantially higher in adults.

Impact: The study provides the largest multicenter European description in the supplied dataset of Moraxella bloodstream infections, including species-specific age patterns and resistance data. Its phylogenomic findings also support updated taxonomy and better diagnostic harmonization.

Clinical Implications: Species-level identification may be clinically relevant because age distribution and cefotaxime resistance differed by species and age group. Local susceptibility testing, improved diagnostic methods, and continued surveillance should guide empiric therapy and antimicrobial stewardship.

Future Directions: Prospective surveillance should link species-level identification and resistance determinants with patient characteristics, antimicrobial treatment, and outcomes. Standardized diagnostic and susceptibility protocols across laboratories would improve comparability and stewardship.